InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Rich Stuart, Directeur Médical. Officer active across 1 company, notably Tenax Therapeutics, INC.. Cumulatively, 5 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €29k. Activity tracked since 12 October 2021. The latest transaction was filed on 8 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rich Stuart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
2,500 股@ US$10.100273.7% 占其流量Common StockSEC:0001841785-25-000004:0
标准退出：2026年3月8日 (T+90)
1,000 股@ US$9.0059100.0% 占其流量Common StockSEC:0001841785-25-000003:0
标准退出：2026年3月2日 (T+90)
1,909,585 股0Common StockSEC:0001654954-22-012922:0
1,909,585 股0Common StockSEC:0001654954-21-012861:0
3,581,000 股Common StockSEC:0001654954-21-006927:0
5 条申报中的 5 条
About Rich Stuart
Rich Stuart is the Chief Medical Officer of TENAX THERAPEUTICS, INC. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Rich brings significant expertise in the medical field, contributing to the mission of TENAX THERAPEUTICS, INC.
